What is Actemra
Actemra is a prescription medication that is used to treat adults with moderate to severe rheumatoid arthritis. It is a biologic medication that is made from human genes. It works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in inflammation.
Benefits of Actemra
and Its Uses.
Actemra (tocilizumab) is a medication used to treat rheumatoid arthritis, juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, and giant cell arteritis. It is a monoclonal antibody that works by blocking the action of interleukin-6 (IL-6), a protein that plays a role in inflammation.
Actemra is given as an intravenous (IV) infusion. It is usually given once a week for the first four weeks, then once every other week.
Actemra may cause side effects, including:
• Muscle pain
• Joint pain
• Difficulty breathing
• Chest pain
• Low blood pressure
Side Effects and Dosage of Actemra
The Food and Drug Administration has approved Actemra (tocilizumab) to treat adults with rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), systemic juvenile idiopathic arthritis (sJIA), giant cell arteritis, and polyarticular juvenile idiopathic arthritis.
Actemra is a monoclonal antibody that blocks the action of interleukin-6 (IL-6), a protein that is thought to play a role in inflammation.
The recommended dosage of Actemra depends on the condition being treated.
For RA, the recommended dose is 8 mg/kg given as an intravenous infusion over 2 hours, followed by a maintenance dose of 4 mg/kg given as an intravenous infusion over 2 hours every 4 weeks.
For JIA, the recommended dose is 10 mg/kg given as an intravenous infusion over 2 hours, followed by a maintenance dose of